KPIs & Operating Metrics(New)
Cash Flow Statement
Growth Metrics

Bausch Health Companies (BHC) Short term Debt (2016 - 2026)

Bausch Health Companies' Short term Debt history spans 17 years, with the latest figure at $889.0 million for Q1 2026.

  • On a quarterly basis, Short term Debt rose 215.25% to $889.0 million in Q1 2026 year-over-year; TTM through Mar 2026 was $889.0 million, a 215.25% increase, with the full-year FY2025 number at $225.0 million, down 91.59% from a year prior.
  • Short term Debt hit $889.0 million in Q1 2026 for Bausch Health Companies, up from $225.0 million in the prior quarter.
  • Over the last five years, Short term Debt for BHC hit a ceiling of $2.7 billion in Q4 2024 and a floor of $150.0 million in Q2 2022.
  • Historically, Short term Debt has averaged $615.0 million across 5 years, with a median of $451.0 million in 2023.
  • Biggest five-year swings in Short term Debt: surged 494.22% in 2024 and later tumbled 91.59% in 2025.
  • Tracing BHC's Short term Debt over 5 years: stood at $432.0 million in 2022, then increased by 4.17% to $450.0 million in 2023, then surged by 494.22% to $2.7 billion in 2024, then tumbled by 91.59% to $225.0 million in 2025, then skyrocketed by 295.11% to $889.0 million in 2026.
  • Business Quant data shows Short term Debt for BHC at $889.0 million in Q1 2026, $225.0 million in Q4 2025, and $579.0 million in Q3 2025.